Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000964175 | SCV000718741 | benign | not provided | 2018-06-27 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000614593 | SCV000863250 | likely benign | not specified | 2018-09-11 | criteria provided, single submitter | clinical testing | |
Laboratory for Molecular Medicine, |
RCV000614593 | SCV000967112 | benign | not specified | 2017-08-23 | criteria provided, single submitter | clinical testing | p.Asn609Asn in exon 14 of FAM65B: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wit hin the splice consensus sequence, and has been identified in 0.51% (326/64054) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.b roadinstitute.org; dbSNP rs145837095). |
Invitae | RCV000964175 | SCV001111364 | benign | not provided | 2024-01-18 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000614593 | SCV001474657 | benign | not specified | 2020-08-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000964175 | SCV001745926 | likely benign | not provided | 2021-06-01 | criteria provided, single submitter | clinical testing |